16798778

Source:http://linkedlifedata.com/resource/pubmed/id/16798778

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0019196, umls-concept:C0021149, umls-concept:C0023911, umls-concept:C0030705, umls-concept:C0034897, umls-concept:C0035525, umls-concept:C0241910, umls-concept:C0277785, umls-concept:C0332293, umls-concept:C0450127, umls-concept:C1515568
pubmed:issue	2
pubmed:dateCreated	2007-2-16
pubmed:abstractText	Interferon may trigger autoimmune disorders, including autoimmune hepatitis, in immunocompetent patients. To date, no such disorders have been described in liver transplanted patients.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/16798778-10518568, http://linkedlifedata.com/resource/pubmed/commentcorrection/16798778-10580593, http://linkedlifedata.com/resource/pubmed/commentcorrection/16798778-10615080, http://linkedlifedata.com/resource/pubmed/commentcorrection/16798778-10807521, http://linkedlifedata.com/resource/pubmed/commentcorrection/16798778-10946266, http://linkedlifedata.com/resource/pubmed/commentcorrection/16798778-11316174, http://linkedlifedata.com/resource/pubmed/commentcorrection/16798778-11391541, http://linkedlifedata.com/resource/pubmed/commentcorrection/16798778-11454184, http://linkedlifedata.com/resource/pubmed/commentcorrection/16798778-11502774, http://linkedlifedata.com/resource/pubmed/commentcorrection/16798778-11826408, http://linkedlifedata.com/resource/pubmed/commentcorrection/16798778-11910899, http://linkedlifedata.com/resource/pubmed/commentcorrection/16798778-12676791, http://linkedlifedata.com/resource/pubmed/commentcorrection/16798778-12737859, http://linkedlifedata.com/resource/pubmed/commentcorrection/16798778-15385825, http://linkedlifedata.com/resource/pubmed/commentcorrection/16798778-3388492, http://linkedlifedata.com/resource/pubmed/commentcorrection/16798778-7308988, http://linkedlifedata.com/resource/pubmed/commentcorrection/16798778-7718001, http://linkedlifedata.com/resource/pubmed/commentcorrection/16798778-7768382, http://linkedlifedata.com/resource/pubmed/commentcorrection/16798778-8930666, http://linkedlifedata.com/resource/pubmed/commentcorrection/16798778-9049215, http://linkedlifedata.com/resource/pubmed/commentcorrection/16798778-9314141, http://linkedlifedata.com/resource/pubmed/commentcorrection/16798778-9482295, http://linkedlifedata.com/resource/pubmed/commentcorrection/16798778-9761770
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/2985108R
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Alanine Transaminase, http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Antinuclear, http://linkedlifedata.com/resource/pubmed/chemical/Antiviral Agents, http://linkedlifedata.com/resource/pubmed/chemical/Hepatitis C Antibodies, http://linkedlifedata.com/resource/pubmed/chemical/Immunosuppressive Agents, http://linkedlifedata.com/resource/pubmed/chemical/Interferon-alpha, http://linkedlifedata.com/resource/pubmed/chemical/Polyethylene Glycols, http://linkedlifedata.com/resource/pubmed/chemical/RNA, Viral, http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Ribavirin, http://linkedlifedata.com/resource/pubmed/chemical/interferon alfa-2b, http://linkedlifedata.com/resource/pubmed/chemical/peginterferon alfa-2b
pubmed:status	MEDLINE
pubmed:month	Feb
pubmed:issn	0017-5749
pubmed:author	pubmed-author:AndreonePP, pubmed-author:BerardiSS, pubmed-author:BernardiMM, pubmed-author:BiselliMM, pubmed-author:BontadiniAA, pubmed-author:D'ErricoAA, pubmed-author:GramenziAA, pubmed-author:GraziGG, pubmed-author:LenziMM, pubmed-author:LodatoFF, pubmed-author:MazzellaGG, pubmed-author:MorelliM CMC, pubmed-author:PinnaA DAD, pubmed-author:PiscagliaFF, pubmed-author:SamaCC, pubmed-author:TamèM RMR
pubmed:issnType	Print
pubmed:volume	56
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	237-42
pubmed:dateRevised	2011-11-17
pubmed:meshHeading	pubmed-meshheading:16798778-Humans, pubmed-meshheading:16798778-Aged, pubmed-meshheading:16798778-Liver Transplantation, pubmed-meshheading:16798778-Female, pubmed-meshheading:16798778-Male, pubmed-meshheading:16798778-Mitochondria, pubmed-meshheading:16798778-Polyethylene Glycols, pubmed-meshheading:16798778-Middle Aged, pubmed-meshheading:16798778-Alanine Transaminase, pubmed-meshheading:16798778-RNA, Viral, pubmed-meshheading:16798778-Recurrence, pubmed-meshheading:16798778-Graft Rejection, pubmed-meshheading:16798778-Antiviral Agents, pubmed-meshheading:16798778-Immunosuppressive Agents, pubmed-meshheading:16798778-Antibodies, Antinuclear, pubmed-meshheading:16798778-Risk Factors, pubmed-meshheading:16798778-Hepatitis, Autoimmune, pubmed-meshheading:16798778-Ribavirin, pubmed-meshheading:16798778-Recombinant Proteins, pubmed-meshheading:16798778-Hepatitis C, pubmed-meshheading:16798778-Interferon-alpha, pubmed-meshheading:16798778-Hepatitis C Antibodies

More...